Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.
about
Does accumulation of advanced glycation end products contribute to the aging phenotype?The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor functionPharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular DiseaseFunctional decorations: post-translational modifications and heart disease delineated by targeted proteomics.Serum carboxymethyl-lysine, disability, and frailty in older persons: the Cardiovascular Health Study.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals.Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification.A receptor-based bioadsorbent to target advanced glycation end products in chronic kidney disease.Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik StudyAdvanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adultsGlyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateHigher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adultsAdvanced glycation end products and oxidative stress in type 2 diabetes mellitus.Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individualsShort telomere length is associated with arterial aging in patients with type 2 diabetes mellitusPlasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.N-butanol extracts of Morinda citrifolia suppress advanced glycation end products (AGE)-induced inflammatory reactions in endothelial cells through its anti-oxidative properties.Skin intrinsic fluorescence is associated with coronary artery disease in individuals with long duration of type 1 diabetesDietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics StudyPositive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography.Plasma Levels of Advanced Glycation End Products Are Related to the Clinical Presentation and Angiographic Severity of Symptomatic Lower Extremity Peripheral Arterial Disease.Analysis of advanced glycation end products in the DHS Mind Study.sRAGE and risk of diabetes, cardiovascular disease, and deathObesity-associated oxidative stress: strategies finalized to improve redox state.The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes.AGE restriction in diabetes mellitus: a paradigm shift.Carboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.Potential inhibitory effects of L-carnitine supplementation on tissue advanced glycation end products in patients with hemodialysisPlasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.Advanced glycation end products (AGE) and diabetes: cause, effect, or both?Investigating wild berries as a dietary approach to reducing the formation of advanced glycation endproducts: chemical correlates of in vitro antiglycation activity.A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness.Incidence of cardiovascular diseases and associated risk factors among subjects with type 2 diabetes - an 11-year follow up studyVascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
P2860
Q24632710-8820083D-AF48-44CE-BD9D-FE696A922B26Q26767495-9856F708-A9B2-453E-A109-219A50B3E7B0Q26782422-6E67640F-4F14-4DEC-820F-0A967366BB16Q30427683-69A5BE1C-A4EE-46E9-B982-514A1715A500Q30578167-D611CF0E-EDAF-46BC-B86D-2796C7C0137CQ33584606-B2EC8A4A-919C-4796-BB8D-073645A4ACDEQ33589073-0D79BCC5-8191-4E8A-B78F-BDF3749786D6Q33594667-CC238B79-9700-410B-9D40-5312BB6BC656Q33602366-9EE40DFB-74B0-4FB1-955D-4C66214B3D72Q33752140-C2275811-1AD0-4C5D-B888-6D2525BD700DQ34213760-652BCB13-785E-4F79-99D5-DEDFA6064744Q34217710-4E9440D1-153E-4348-9D76-4501C3067204Q34286094-3E44F99C-B122-48FF-81D2-FF10BEF7A95BQ34507243-A963F354-7D56-401A-AEE0-01008B2057C3Q34564061-B0D26432-AB39-4E5C-B9C0-07BE48FFD556Q34981419-25D7208B-5A2C-40B7-A33E-36A961E20230Q35173430-236C3182-93BB-4BDB-ACF2-748C034AD16FQ35255473-3F0CF3F8-A71E-47BC-A0DB-08DA10FFF612Q35578295-7D610EC9-43B0-40BC-9ACC-C557F3D747CEQ35626858-5EE60E16-0520-4D99-B2B4-3B7166C39D4CQ35775500-3902F5CE-71C6-4A56-A3F4-C048073A02A4Q36152748-75BB4406-092C-4D25-9C88-CE3D76F81533Q36297295-03664039-BE00-4E3C-B126-E59AE639BDF2Q36334531-BFB9630D-8D48-4584-9A59-799375DC7DA1Q36364486-AD89F7D3-2EF0-4B40-BDD9-2DB71C011B6FQ36426832-8CDF37A7-8F2D-490A-AFE1-C55F18CF91AEQ36593852-2EFA49A4-F522-4461-80E3-9516F8C71D1FQ36600193-C6D82B9E-5FA3-44ED-A8C9-1CF4034926B5Q36867450-ACFB8315-2900-456B-A78D-0535989DB71BQ36913776-85D59861-A86B-46CC-B615-1AB29DFAF386Q36942530-AA481D38-9C21-42C5-85F0-8E6387BE435AQ37003623-55A9FE24-4357-4952-9D7F-04011CB46C75Q37056383-D02412F5-D97F-4516-92F2-158D3A493BDFQ37406686-DEEDC655-E9CB-4F76-87B5-57F7CA80A4D5Q37445850-4ECEF263-773A-497B-A0F5-7EA8CDDB23FEQ37520014-F1DE9B28-561C-421C-81AB-C993AC2D8FC6Q37595925-1DD809B1-2263-4858-9A24-DD92CA2ECCEDQ37622708-816F2EC7-E7E7-4F8F-8477-30AC0E611D77Q37624467-2CC546CF-6624-4506-81DA-F19DC3F7E575Q37636453-F12869A5-02AF-4631-9B18-FA39DBC44D87
P2860
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Increased serum levels of adva ...... based 18 year follow-up study.
@en
Increased serum levels of adva ...... based 18 year follow-up study.
@nl
type
label
Increased serum levels of adva ...... based 18 year follow-up study.
@en
Increased serum levels of adva ...... based 18 year follow-up study.
@nl
prefLabel
Increased serum levels of adva ...... based 18 year follow-up study.
@en
Increased serum levels of adva ...... based 18 year follow-up study.
@nl
P2093
P1433
P1476
Increased serum levels of adva ...... based 18 year follow-up study.
@en
P2093
A Juutilainen
B K Kilhovd
K F Hanssen
P A Torjesen
T Rönnemaa
P2888
P304
P356
10.1007/S00125-007-0687-Z
P577
2007-05-04T00:00:00Z